Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03485729
Title	ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
Recruitment	Terminated
Gender	female
Phase	Phase II
Variant Requirements	No
Sponsors	Oncoceutics, Inc.
Indications	uterine carcinosarcoma endometrial cancer
Therapies	ONC201
Age Groups:	senior \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 3 of 3 entries

Facility	City	State	Zip	Country	Details
Fox Chase Cancer Center	Philadelphia	Pennsylvania	19111	United States	Details
Rutgers, The State University of New Jersey	New Brunswick	New Jersey	08903	United States	Details
UNC Lineberger Comprehensive Cancer Center	Chapel Hill	North Carolina	27599	United States	Details

Showing 1 to 3 of 3 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field